Literature DB >> 30927332

Mechanistic insights into Nav1.7-dependent regulation of rat prostate cancer cell invasiveness revealed by toxin probes and proteomic analysis.

Bo Chen1,2, Changxin Zhang2, Zijun Wang2, Yan Chen1, Huali Xie1, Sha Li1, Xiaoqian Liu1, Zhonghua Liu1,2, Ping Chen1,2.   

Abstract

Voltage-gated sodium channels are involved in tumor metastasis, as potentiating or attenuating their activities affects the migration and invasion process of tumor cells. In the present study, we tested the effect of two peptide toxins, JZTX-I and HNTX-III which function as Nav1.7 activator and inhibitor, respectively, on the migration and invasion ability of prostate cancer (PCa) cell line Mat-LyLu. These two peptides showed opposite effects, and subsequently a comparative proteomic analysis characterized 64 differentially expressed membrane proteins from the JZTX-I- and HNTX-III-treated groups. Among these, 15 proteins were down-regulated and 49 proteins were up-regulated in the HNTX-III group. Bioinformatic analysis showed eight proteins are cytoskeleton proteins or related regulators, which might play important roles in the metastasis of Mat-LyLu cells. The altered expressions of four of these proteins, fascin, muskelin, annexin A2, and cofilin-1, were validated by western blot analysis. Further function network analysis of these proteins revealed that the Rho family GTPases RhoA and Rac1 might be of particular importance for the rat PCa cell invasion. Pharmacological data revealed that JZTX-I and HNTX-III could modulate the Rho signaling pathway in a Nav1.7-dependent manner. In summary, this study suggests that the Nav1.7-dependent regulation of Rho GTPase activity plays a vital role in Mat-LyLu cell migration and invasion and provides new insights into the treatment of PCa.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  Nav1.7; invasiveness; prostate cancer; proteomics; toxin probes

Year:  2019        PMID: 30927332     DOI: 10.1111/febs.14823

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  10 in total

Review 1.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 2.  Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment.

Authors:  Gulimirerouzi Fnu; Georg F Weber
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

3.  Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance.

Authors:  Chuan Liu; Chuan Hu; Zhi Li; Jing Feng; Jiale Huang; Bowen Yang; Ti Wen
Journal:  Cancer Cell Int       Date:  2020-06-30       Impact factor: 5.722

4.  Chemical Synthesis, Proper Folding, Nav Channel Selectivity Profile and Analgesic Properties of the Spider Peptide Phlotoxin 1.

Authors:  Sébastien Nicolas; Claude Zoukimian; Frank Bosmans; Jérôme Montnach; Sylvie Diochot; Eva Cuypers; Stephan De Waard; Rémy Béroud; Dietrich Mebs; David Craik; Didier Boturyn; Michel Lazdunski; Jan Tytgat; Michel De Waard
Journal:  Toxins (Basel)       Date:  2019-06-21       Impact factor: 4.546

Review 5.  In Vivo Evidence for Voltage-Gated Sodium Channel Expression in Carcinomas and Potentiation of Metastasis.

Authors:  Mustafa B A Djamgoz; Scott P Fraser; William J Brackenbury
Journal:  Cancers (Basel)       Date:  2019-10-28       Impact factor: 6.639

Review 6.  Targeting Rac and Cdc42 GEFs in Metastatic Cancer.

Authors:  Maria Del Mar Maldonado; Julia Isabel Medina; Luis Velazquez; Suranganie Dharmawardhane
Journal:  Front Cell Dev Biol       Date:  2020-04-08

7.  Dynein and muskelin control myosin VI delivery towards the neuronal nucleus.

Authors:  Matthias Kneussel; Noelia Sánchez-Rodríguez; Michaela Mischak; Frank F Heisler
Journal:  iScience       Date:  2021-04-09

8.  Phosphoproteomics Identifies Significant Biomarkers Associated with the Proliferation and Metastasis of Prostate Cancer.

Authors:  Rongfang Xu; Yan Chen; Zijun Wang; Changxin Zhang; Xiaoping Dong; Yujie Yan; Ying Wang; Yong Zeng; Ping Chen
Journal:  Toxins (Basel)       Date:  2021-08-09       Impact factor: 4.546

9.  Therapeutic potential of TRPM8 antagonists in prostate cancer.

Authors:  Marzia Di Donato; Carmine Ostacolo; Pia Giovannelli; Veronica Di Sarno; Isabel M Gomez Monterrey; Pietro Campiglia; Antimo Migliaccio; Alessia Bertamino; Gabriella Castoria
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

10.  Voltage-dependent activation of Rac1 by Nav 1.5 channels promotes cell migration.

Authors:  Ming Yang; Andrew D James; Rakesh Suman; Richard Kasprowicz; Michaela Nelson; Peter J O'Toole; William J Brackenbury
Journal:  J Cell Physiol       Date:  2019-10-15       Impact factor: 6.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.